PharmaTher Holdings Income Statement

Financials in millions CAD. Fiscal year is June - May.

Millions CAD. Fiscal year is Jun - May.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May '26 May 31, 2026	May '25 May 31, 2025	May '24 May 31, 2024	May '23 May 31, 2023	May '22 May 31, 2022
Selling, General & Admin	0.63	0.78	0.9	0.94	1.36
Research & Development	0.15	0.58	2.14	3.02	2.61
Operating Expenses	0.78	1.52	3.04	3.96	3.96
Operating Income	-0.78	-1.52	-3.04	-3.96	-3.96
Interest & Investment Income	0	0.06	0.19	0.21	-
Earnings From Equity Investments	-0.01	-0.05	-0.05	-	-
Other Non Operating Income (Expenses)	-0.07	-0.05	-0.04	-0.03	-0.14
EBT Excluding Unusual Items	-0.85	-1.56	-2.95	-3.78	-4.1
Gain (Loss) on Sale of Investments	0.03	0.03	-0.17	-2.63	-0.13
Gain (Loss) on Sale of Assets	0.21	-	-	-	-
Pretax Income	-0.61	-1.53	-3.12	-6.42	-4.24
Income Tax Expense	-	-	-	-	-0.23
Net Income	-0.61	-1.53	-3.12	-6.42	-4.01
Net Income to Common	-0.61	-1.53	-3.12	-6.42	-4.01
Net Income Growth	-	-	-	-	-
Shares Outstanding (Basic)	91	89	88	88	81
Shares Outstanding (Diluted)	91	89	88	88	81
Shares Change	2.82%	0.33%	0.07%	8.71%	10.70%
EPS (Basic)	-0.01	-0.02	-0.04	-0.07	-0.05
EPS (Diluted)	-0.01	-0.02	-0.04	-0.07	-0.05
EPS Growth	-	-	-	-	-

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May '26 May 31, 2026	May '25 May 31, 2025	May '24 May 31, 2024	May '23 May 31, 2023	May '22 May 31, 2022
Free Cash Flow	-0.49	-1.21	-3.52	-3.24	-3.51
Free Cash Flow Per Share	-0.01	-0.01	-0.04	-0.04	-0.04
EBITDA	-	-1.52	-3.04	-3.96	-3.96
D&A For EBITDA	-	0	0	0	0
EBIT	-0.78	-1.52	-3.04	-3.96	-3.96